siteLogo
U M DONATE

Termeer Foundation Announces Class of 2024 Fellows

Apr 10, 2024

Fellowship Recipients Show Deep Commitment Toward Innovation and Patient-Focused Care 

BOSTON, MA (April 10, 2024) – The Termeer Foundation, a nonprofit organization working to connect and promote the world of healthcare innovators until every patient has a cure, is proud to announce its Class of 2024 Termeer Fellows.

 The Termeer Foundation is committed to continuing Henri Termeer’s legacy of leadership success by infusing and sustaining the pipeline of current and future leaders to increase the probability of solving healthcare’s greatest challenges. The Termeer Fellowship provides first time CEOs the opportunity to participate in a values-driven leadership program, as well as receive mentorship from industry leaders and build their network through access to the Termeer Network. 

“The Termeer Fellowship is more than an award; it embodies the essence of Henri’s commitment to transforming patient-centered care,” said Belinda Termeer, President and Co-Founder of the Termeer Foundation. “This year’s Fellows are not just scientists or entrepreneurs, but trailblazers fueled by a passion to address the most pressing health challenges of our time.

 “We are thrilled to welcome this new class of Termeer Fellows,” said Catharine Smith, Executive Director of the Termeer Foundation. “Now entering the Fellowship’s seventh year, we’re excited to offer our incoming class the support and mentorship they need to be values-driven leaders and to build impactful companies. Our goal is clear: to create a future where every patient has a cure through healthcare innovation. Together, we’re making this vision a reality.”

 The Termeer Foundation received 69 applications for this prestigious program. With the support of Termeer’s selection committee, 15 Fellows were named. “As an alumna of the Fellowship, it was an honor to be a part of selecting the Class of 2024,” said Dr. Minmin Yen, CEO and Co-Founder of PhagePro Inc. and 2020 Termeer Fellow. “Through the values-driven leadership and  professional development training,  mentorship, and network building offered with this opportunity, Fellows will receive a broader understanding of what it means to be a leader and the tools and resources needed to be successful.”

 Please join us in welcoming our 2024 Class of Termeer Fellows:

  • Hanne Callewaert, Co-Founder and CEO of AstriVax
  • Tinashe Chandauka, Co-Founder and CEO of Nandi Life Sciences
  • Ying Kai Chan, Co-Founder and CEO of Cirrus Therapeutics
  • Aaron Edwards, CEO and Co-Founder of KiraGen Bio
  • Floris Engelhardt, Co-Founder and CEO of Kano Therapeutics
  • Manuel Marina Breysse, CEO and Co-Founder of Idoven
  • Natalie Nairn, Co-Founder, CEO, and CSO of Cyclera Therapeutics
  • Nabanita Nawar, CEO and Co-Founder of HDAX Therapeutics
  • Richard Novak, Co-Founder and CEO of Unravel Biosciences
  • Catherine Sabatos-Peyton, CEO of Larkspur Biosciences
  • Shardule Shah, CEO and Co-Founder of Lime Therapeutics
  • Carla Spina, CEO and Co-Founder of Noa Therapeutics
  • Theresa Tribble, CEO of Droplet Biosciences
  • Fernando Vieira, CEO and CSO at the ALS Therapy Development Institute
  • Dan Jing Wu, CEO and Co-Founder, VivArt-X

 

About the Termeer Fellowship Program

The Termeer Fellowship Program supports first-time CEOs who are patient-focused and working to meet an unmet need through innovative science and passion. The support of the Termeer Foundation includes mentoring, networking, and professional development intended to facilitate connections, break down silos, strengthen skill sets, and ultimately enable a diverse array of current and future healthcare leaders who bring much-needed solutions to patients. Termeer Fellows have access to a network of industry leaders and mentors, opportunities for in-person and virtual network building, as well as professional and leadership development programming provided by top executive coaches and leadership development consultants.

 

About The Termeer Foundation

The Termeer Foundation is a nonprofit organization working to connect the world of healthcare innovators until every patient has a cure. The Termeer Foundation  builds and supports an ever-expanding network of biotech entrepreneurs, CEOs, academics, and other innovators because helping people succeed will ultimately help their innovations reach patients. Support includes mentoring, networking, professional development, and financial grants intended to facilitate connections, break down silos, strengthen skill sets, and ultimately enable a diverse array of current and future healthcare leaders who bring much-needed solutions to patients. Find out more about The Termeer Foundation and how you can support, engage with, and join its network at www.termeerfoundation.org or on LinkedIn @TermeerFoundation.

 

For questions about the Termeer Fellowship Program, contact:

Catharine Smith

Executive Director, Termeer Foundation

catharine@termeerfoundation.org

Termeer Institute Announces 2026 Transatlantic Connections Award Honorees

Shana Wang of PathCision Medicine and Arno Bisschop of Genewity Named as This Year's Recipients

The Termeer Institute today announced the recipients of the 2026 Transatlantic Connections Award (TAC), recognizing two life sciences entrepreneurs — one in the United States and one in the Netherlands — whose work has the potential to strengthen the relationship and thought partnership between the two regions’ life sciences communities.

This year’s honorees are Shana Wang, co-founder and CEO of PathCision Medicine (United States), and Arno Bisschop, CEO of Genewity (Netherlands). Both honorees join the Class of 2026 Termeer Fellows and become members of the Termeer network. Each will receive support to travel to and engage with the life sciences community in the other’s region.

The Transatlantic Connections Award was established in 2021 with support from the Termeer Institute and Health-Holland, and is rooted in the Massachusetts–Netherlands life sciences partnership formalized through a 2019 memorandum of understanding between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy.

“Scientific discovery knows no borders, and the Transatlantic Connections Award reflects that belief,” said Catharine Smith, CEO of the Termeer Institute. “Shana and Arno each bring deep expertise and a patient-first orientation to their work. We look forward to seeing the connections they build as members of the Termeer network and the exchange of ideas that will follow.”

Shana Wang, Co-Founder and CEO, PathCision Medicine

Shana Wang, co-founder and CEO of PathCision Medicine, brings a background in analytics, strategy and operational leadership to her work in life sciences. Prior to founding PathCision, she served as head of marketing and analytics at a femtech company, where she led cross-functional teams to launch new products and implemented data-driven strategies to support market growth. Earlier in her career, she worked in strategy and analytics consulting, advising Fortune 500 companies and developing predictive models to support data-informed decisions. She holds an M.A. in computational and applied mathematics from Rice University and a B.A. in economics and English from Wellesley College.

“Being named a Transatlantic Connections Award honoree is an extraordinary opportunity to learn from and contribute to a community of leaders united by a commitment to patients,” said Shana Wang, co-founder and CEO of PathCision Medicine. “I look forward to building connections across the Atlantic and bringing those perspectives to the work we are doing.”

Arno Bisschop, CEO, Genewity

Arno Bisschop is a medical doctor and entrepreneur in health and life sciences. Trained at the Amsterdam University Medical Center, he holds a PhD in orthopedic and neurosurgery and a master’s degree in management and policy in health and life sciences. Over the past decade, Bisschop has co-founded and exited several health care companies. He currently serves as CEO of Genewity, a clinical-stage company developing gene therapies for patients around the world.

“I am honored to receive the Transatlantic Connections Award and to join the Termeer Fellows community,” said Arno Bisschop, CEO of Genewity. “Collaboration across regions is essential to advancing the science and solutions that patients need, and I look forward to building those connections.”

Wang and Bisschop join a Termeer network that includes more than 600 life science industry leaders— mentors, advisors, board members and community partners — spanning nine countries and united by a shared commitment to patient-centered innovation. Fellows across the program’s history have collectively raised $3.45 billion in funding, with 73% remaining in their roles as CEOs and 87% of their companies continuing to advance. The exchange of ideas and experiences across borders is central to how the Institute drives progress, with the ultimate goal that every patient has a cure.

About the Transatlantic Connections Award 

The Transatlantic Connections Award recognizes one U.S.-based and one Netherlands-based life sciences entrepreneur annually. Honorees become members of the Termeer Fellows class and the broader Termeer network, and receive support to engage with the life sciences community in the other’s region. The award was established in 2021 with support from the Termeer Institute and Health-Holland.

About the Termeer Institute 

The Termeer Institute supports and empowers brilliant life science innovators through values-driven leadership programming, including mentorship, network development and thought leadership to advance groundbreaking, patient-centric solutions. Learn more at termeerinstitute.org.